|23.48||-2.59||-9.93%||Vol 1.33M||1Y Perf -67.56%|
|Aug 9th, 2022 16:00 DELAYED|
|- -||-0.32 -1.36%|
|Target Price||45.67||Analyst Rating||Strong Buy 1.50|
|Potential %||94.51||Finscreener Ranking||★★★★ 53.72|
|Insiders Trans % 3/6/12 mo.||-100/-100/-91||Value Ranking||★★★★ 56.10|
|Insiders Value % 3/6/12 mo.||-100/-100/-95||Growth Ranking||★★★★ 57.05|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-94||Income Ranking||— -|
|Price Range Ratio 52W %||6.60||Earnings Rating||Strong Sell|
|Market Cap||1.26B||Earnings Date||4th Aug 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|5 Years||1 652.24%|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.30|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||953.54K|
|Avg. Monthly Volume||718.23K|
|Avg. Quarterly Volume||879.42K|
CareDx Inc. (NASDAQ: CDNA) stock closed at 23.48 per share at the end of the most recent trading day (a -9.93% change compared to the prior day closing price) with a volume of 1.33M shares and market capitalization of 1.26B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 475 people. CareDx Inc. CEO is Reginald Seeto.
The one-year performance of CareDx Inc. stock is -67.56%, while year-to-date (YTD) performance is -48.37%. CDNA stock has a five-year performance of 1652.24%. Its 52-week range is between 19.345 and 82.03, which gives CDNA stock a 52-week price range ratio of 6.60%
CareDx Inc. currently has a PE ratio of -24.10, a price-to-book (PB) ratio of 2.66, a price-to-sale (PS) ratio of 4.91, a price to cashflow ratio of 1 429.20, a PEG ratio of 2.32, a ROA of -9.38%, a ROC of -10.26% and a ROE of -10.99%. The company’s profit margin is -19.96%, its EBITDA margin is -11.40%, and its revenue ttm is $234.22 Million , which makes it $4.40 revenue per share.
Of the last four earnings reports from CareDx Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.30 for the next earnings report. CareDx Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for CareDx Inc. is Strong Buy (1.5), with a target price of $45.67, which is +94.51% compared to the current price. The earnings rating for CareDx Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
CareDx Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
CareDx Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 20.22, ATR14 : 2.27, CCI20 : -36.44, Chaikin Money Flow : 0.00, MACD : 0.25, Money Flow Index : 55.37, ROC : 1.29, RSI : 32.96, STOCH (14,3) : 30.88, STOCH RSI : 0.50, UO : 55.13, Williams %R : -69.12), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of CareDx Inc. in the last 12-months were: Ankur Dhingra (Buy at a value of $211 694), Arthur A. Torres (Buy at a value of $28 572), George W. Bickerstaff (Sold 25 000 shares of value $977 673 ), Grace Colon (Sold 6 572 shares of value $167 315 ), Michael D. Goldberg (Option Excercise at a value of $4 270), Michael D. Goldberg (Sold 3 500 shares of value $155 402 ), Peter Maag (Option Excercise at a value of $1 163 373), Peter Maag (Sold 90 000 shares of value $4 840 585 ), Reginald Seeto (Option Excercise at a value of $299 958), Reginald Seeto (Sold 23 089 shares of value $967 232 )
Sat, 07 May 2022 03:40 GMT CareDx (CDNA) Gets a Buy Rating from BTIG- TipRanks. All rights reserved.
Tue, 11 Jan 2022 11:26 GMT CareDx (CDNA) Gets a Hold Rating from H.C. Wainwright- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.